Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair.

He, Xingyu; Liang, Jialiang; Paul, Christian; Huang, Wei; Dutta, Suchandrima; Wang, Yigang

He, Xingyu; Liang, Jialiang; Paul, Christian; Huang, Wei; Dutta, Suchandrima; Wang, Yigang.

Afiliación

He X; Department of Pathology & Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.
Liang J; Department of Pathology & Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.
Paul C; Department of Pathology & Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.
Huang W; Department of Pathology & Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.
Dutta S; Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.
Wang Y; Department of Pathology & Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.

Cells ; 11(23)2022 Dec 03.

Article en En | MEDLINE | ID: mdl-36497171

Asunto(s)

Cardiopatías; Células Madre Pluripotentes Inducidas; Adulto; Humanos; Reprogramación Celular; Células Madre Pluripotentes Inducidas/metabolismo; Técnicas de Reprogramación Celular/métodos; Miocitos Cardíacos/metabolismo; Medicina Regenerativa/métodos; Cardiopatías/metabolismo

Palabras clave

direct reprogramming; engineered heart tissue; iPSC-CMs; immune reduction; myocadiac infarction; progenitor cells; regenerative heart repair; stem cells

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas / Cardiopatías Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google